All India Institute of Medical Sciences (AIIMS) Delhi will start recruitment for clinical trials of the indigenous Bharat Biotech’s Covid-19 vaccine “Covaxin” from Tuesday on 6-12 years of age.
ANI reports that recruitment and clinical trials for single-dose COVAXIN for 12-18 age group is over and they have been given a single dose of vaccine.
After the recruitment of 6-12 year old children, AIIMS Delhi will be conducting trials for the age group of 2-6 year old. The trials are taking place at 525 centres.
Explore the profound effects of excessive screen time on your child’s behavior and development. Discover…
Discover how simple daily changes in your diet and lifestyle can significantly improve your heart…
This article explores the common misconception that brain tumours primarily affect older adults, revealing the…
The first-ever ovarian cancer vaccine is poised to change the landscape of women's health by…
As dengue and chikungunya cases rise in Delhi during the monsoon season, understanding prevention strategies…
Skincare is a significant concern for women (and increasingly, men), with the quest for perfect,…